Full Text PDF Similar Articles Mail to Author

¹Department of Radiation Oncology, Eskişehir Osmangazi University Faculty of Medicine, Eskişehir-Turkey
²Department of Radiation Oncology, İstinye University Faculty of Medicine, İstanbul-Turkey DOI : 10.5505/tjo.2022.S1007 Radiotherapy (RT) is the cornerstone component of the current successful treatment of Hodgkin lymphoma (HL). Although RT has been used alone to cure in most patients in decades, combined modality regimes are preferred in most HL patients currently, besides early-stage lymphocyte predominance HL and for selected patients with classical HL who have contraindications to chemotherapy. Although classic RT fields, doses, and techniques have fundamentally changed over the years, the heart is still an organ at risk, and patients with radiation-induced cardiovascular complications are increased in the long term. In this paper, we aimed to review literature about radiation-induced cardiotoxicity in lymphoma patients treated with mediastinal RT. Keywords : Cardiotoxicity; Hodgkin Lymphoma (HL); radiotherapy